Practical_JJ Approach_NN for_IN Typing_NP Strains_NP of_IN Leishmania_NP infantum_NN by_IN Microsatellite_NP Analysis_NP Currently_RB the_DT universally_RB accepted_VBN standard_JJ procedure_NN for_IN characterizing_VBG and_CC identifying_VBG strains_NNS of_IN Leishmania_NP is_VBZ isoenzyme_NN analysis_NN ._SENT However_RB ,_, in_IN the_DT Mediterranean_JJ area_NN ,_, despite_IN their_PP$ very_RB wide_JJ geographical_JJ distribution_NN ,_, most_JJS Leishmania_NP infantum_NN strains_NNS belong_VBP to_TO zymodeme_NP MON-1_NP ._SENT In_IN order_NN to_TO increase_VB our_PP$ understanding_NN of_IN polymorphism_NN in_IN strains_NNS of_IN L._NP infantum_NN ,_, we_PP developed_VBD PCR_NP assays_NNS amplifying_VBG 10_CD microsatellites_NNS and_CC sequenced_JJ PCR_NP products_NNS ._SENT The_DT discriminative_JJ power_NN of_IN microsatellite_NN analysis_NN was_VBD tested_VBN by_IN using_VBG a_DT panel_NN of_IN 50_CD L._NP infantum_NN strains_NNS collected_VBN from_IN patients_NNS and_CC dogs_NNS from_IN Spain_NP ,_, France_NP ,_, and_CC Israel_NP ,_, including_VBG 32_CD strains_NNS belonging_VBG to_TO zymodeme_NP MON-1_NP ,_, 8_CD strains_NNS belonging_VBG to_TO zymodemes_NP MON-24_NP ,_, MON-29_NP ,_, MON-33_NP ,_, MON-34_NP ,_, or_CC MON-80_NP ,_, and_CC 10_CD untyped_JJ strains_NNS ._SENT Five_CD of_IN the_DT microsatellites_NNS were_VBD polymorphic_JJ ,_, revealing_VBG 22_CD genotypes_NNS ,_, whereas_IN the_DT five_CD remaining_VBG microsatellites_NNS were_VBD not_RB variable_JJ ._SENT In_IN particular_JJ ,_, MON-1_JJ strains_NNS could_MD be_VB separated_VBN into_IN 13_CD different_JJ closely_RB related_VBN genotypes_NNS ._SENT MON-33_NP and_CC MON-34_NP strains_NNS also_RB gave_VBD two_CD additional_JJ genotypes_NNS closely_RB related_VBN to_TO MON-1_NP ,_, while_IN MON-29_NP ,_, MON-24_NP ,_, and_CC MON_NP 80_CD strains_NNS exhibited_VBN more_RBR divergent_JJ genotypes_NNS ._SENT Among_IN the_DT foci_NNS examined_VBD ,_, the_DT Catalonian_NP focus_NN displayed_VBD a_DT high_JJ polymorphism_NN ,_, probably_RB reflecting_VBG isoenzyme_NN polymorphism_NN ,_, while_IN the_DT Israeli_JJ focus_NN exhibited_VBD a_DT low_JJ polymorphism_NN that_WDT could_MD be_VB consistent_JJ with_IN the_DT recent_JJ reemergence_NN and_CC rapid_JJ spread_NN of_IN canine_JJ leishmaniasis_NN in_IN northern_JJ and_CC central_JJ Israel_NP ._SENT The_DT strains_NNS originating_VBG from_IN the_DT south_NN of_IN France_NP and_CC the_DT Madrid_NP ,_, Spain_NP ,_, area_NN displayed_VBD significant_JJ microsatellite_NN polymorphism_NN even_RB though_IN they_PP were_VBD monomorphic_JJ by_IN isoenzyme_NN analysis_NN ._SENT In_IN conclusion_NN ,_, microsatellite_NN polymorphism_NN exhibits_VBZ a_DT high_JJ discriminative_JJ power_NN and_CC appears_VBZ to_TO be_VB suitable_JJ for_IN characterization_NN of_IN closely_RB related_VBN strains_NNS of_IN L._NP infantum_NN in_IN epidemiological_JJ studies_NNS ._SENT Protozoan_JJ parasites_NNS of_IN the_DT genus_NN Leishmania_NP cause_VBP a_DT spectrum_NN of_IN diseases_NNS ,_, ranging_VBG from_IN self-limiting_NN ,_, self-curing_VBG cutaneous_JJ leishmaniasis_NN (_( CL_NP )_) to_TO disseminating_VBG ,_, fatal_JJ visceral_JJ leishmaniasis_NN ,_, and_CC they_PP infect_VBP various_JJ mammalian_JJ hosts_NNS ._SENT Leishmania_NN infantum_NN may_MD cause_VB either_DT simple_JJ CL_NP ,_, debilitating_JJ visceral_JJ leishmaniasis_NN ,_, or_CC asymptomatic_JJ cases_NNS ._SENT Currently_RB ,_, the_DT universally_RB accepted_VBN standard_JJ procedure_NN for_IN characterizing_VBG and_CC identifying_VBG strains_NNS of_IN Leishmania_NP is_VBZ isoenzyme_NN analysis_NN ._SENT However_RB ,_, this_DT is_VBZ performed_VBN only_RB in_IN a_DT few_JJ laboratories_NNS and_CC is_VBZ ,_, depending_VBG on_IN the_DT number_NN of_IN enzymes_NNS examined_VBD ,_, very_RB labor_NN intensive_NN and_CC time_NN consuming_NN ._SENT Unlike_IN some_DT species_NN of_IN Leishmania_NP ,_, e.g._FW ,_, Leishmaniatropica_NP and_CC Leishmania_NP major_NN ,_, which_WDT exhibit_VBP extensive_JJ enzymatic_JJ polymorphism_NN ,_, most_JJS L._NP infantum_NN strains_NNS isolated_VBN in_IN Mediterranean_JJ foci_NNS belong_VBP to_TO the_DT sole_JJ predominant_JJ zymodeme_NN MON-1_NP ,_, despite_IN their_PP$ very_RB wide_JJ geographical_JJ distribution_NN ._SENT Indeed_RB ,_, except_IN in_IN some_DT foci_NNS ,_, where_WRB significant_JJ enzymatic_JJ polymorphism_NN has_VBZ been_VBN found_VBN among_IN strains_NNS of_IN L._NP infantum_NN ,_, in_IN most_RBS Mediterranean_JJ foci_NNS ,_, such_JJ as_IN Provence_NP in_IN southern_JJ France_NP or_CC Israel_NP ,_, nearly_RB all_RB of_IN the_DT strains_NNS of_IN L._NP infantum_NN belong_VBP to_TO the_DT zymodeme_NN MON-1_NN ._SENT In_IN these_DT foci_NNS ,_, the_DT insufficient_JJ discriminative_JJ power_NN of_IN isoenzyme_NN typing_VBG methods_NNS prevents_VBZ researchers_NNS from_IN establishing_VBG correlations_NNS between_IN clinical_JJ feature_NN ,_, preferential_JJ host_NN (_( dogs_NNS ,_, immunocompetent_JJ children_NNS ,_, and_CC human_JJ immunodeficiency_NN virus_NN [_SYM HIV]-infected_JJ patients_NNS )_) ,_, and_CC particular_JJ group_NN of_IN strains_NNS ._SENT In_IN the_DT same_JJ way_NN ,_, the_DT lack_NN of_IN discrimination_NN between_IN strains_NNS also_RB prevents_VBZ genetic_JJ studies_NNS on_IN parasite_NN populations_NNS ._SENT Several_JJ molecular_JJ biological_JJ typing_VBG methods_NNS have_VBP been_VBN developed_VBN to_TO improve_VB the_DT discriminative_JJ power_NN of_IN typing_VBG methods_NNS for_IN the_DT genus_NN Leishmania_NP ._SENT These_DT include_VBP amplification_NN of_IN a_DT parasite_NN DNA_NN sequence_NN by_IN either_CC a_DT specific_JJ PCR_NP or_CC a_DT random_JJ amplified_VBN polymorphic_JJ DNA_NP (_( RAPD_NP )_) PCR_NP or_CC detection_NN of_IN restriction_NN fragment_NN length_NN polymorphisms_NNS (_( RFLPs_NP )_) by_IN Southern_JJ hybridization_NN with_IN DNA-specific_JJ probes_NNS ._SENT The_DT last_JJ two_CD methods_NNS have_VB drawbacks_NNS ._SENT RFLP_NN analysis_NN is_VBZ a_DT time-consuming_JJ technique_NN and_CC large_JJ amounts_NNS of_IN purified_VBN DNA_NN are_VBP needed_VBN ,_, whereas_IN RAPD_NN analysis_NN requires_VBZ strict_JJ conditions_NNS to_TO obtain_VB reproducibility_NN between_IN different_JJ laboratories_NNS and_CC generates_VBZ complex_JJ patterns_NNS ._SENT In_IN contrast_NN ,_, specific_JJ PCR-based_JJ methods_NNS are_VBP attractive_JJ because_IN of_IN their_PP$ rapidity_NN and_CC because_IN culturing_VBG parasites_NNS can_MD be_VB avoided_VBN ._SENT However_RB ,_, in_IN most_JJS cases_NNS ,_, the_DT level_NN of_IN polymorphism_NN found_VBN with_IN coding_VBG or_CC repeated_VBN noncoding_JJ PCR-amplified_JJ sequences_NNS is_VBZ not_RB refined_VBN enough_RB to_TO distinguish_VB between_IN closely_RB related_VBN strains_NNS ._SENT Microsatellite_NP DNA_NP sequences_NNS ,_, tandem_JJ repeats_NNS of_IN a_DT simple_JJ nucleotide_NN motif_NN ,_, are_VBP distributed_VBN abundantly_RB in_IN the_DT eukaryotic_JJ genomes_NNS and_CC may_MD reveal_VB important_JJ strain_NN polymorphisms_NNS ._SENT However_RB ,_, until_IN now_RB only_RB two_CD microsatellites_NNS showing_VBG size_NN polymorphism_NN have_VBP been_VBN identified_VBN and_CC characterized_VBN for_IN L._NP infantum_NN ._SENT Usually_RB ,_, to_TO study_VB microsatellites_NNS ,_, investigators_NNS screen_VBP a_DT genomic_JJ DNA_NN library_NN and_CC then_RB evaluate_VB the_DT microsatellite_JJ size_NN polymorphism_NN by_IN PCR_NP amplification_NN and_CC electrophoresis_NN on_IN acrylamide_NN gels_NNS ._SENT In_IN the_DT present_JJ study_NN ,_, we_PP looked_VBD for_IN new_JJ microsatellites_NNS in_IN the_DT genome_NN of_IN Leishmania_NP without_IN performing_VBG genomic_JJ library_NN screening_NN ._SENT Microsatellites_NNS were_VBD selected_VBN from_IN leishmanial_NN DNA_NN sequences_NNS published_VBN in_IN data_NN banks_NNS and_CC particularly_RB from_IN the_DT L._NP major_JJ chromosome_NN 1_CD genome_NN ._SENT The_DT polymorphism_NN of_IN the_DT microsatellite_JJ DNA_NN sequences_NNS was_VBD evaluated_VBN by_IN comparative_JJ analysis_NN of_IN the_DT PCR_NP product_NN sequences_NNS of_IN 50_CD strains_NNS of_IN L._NP infantum_NN collected_VBN in_IN four_CD Mediterranean_JJ regions_NNS of_IN endemicity_NN :_: Catalonia_NP and_CC Madrid_NP ,_, Spain_NP ;_: Provence_NP ,_, France_NP ;_: and_CC northern_JJ and_CC central_JJ Israel_NP ._SENT Strategy_NN ._SENT |_SYM Potential_JJ targets_NNS for_IN PCR_NP amplification_NN were_VBD selected_VBN from_IN the_DT leishmanial_NN DNA_NN sequences_NNS available_JJ in_IN the_DT GenBank_NP database_NN ._SENT Since_IN most_JJS of_IN them_PP were_VBD located_VBN on_IN chromosome_NN 1_CD of_IN L._NP major_JJ MHOM/IL/81/Friedlin_NP ,_, we_PP used_VBD a_DT pragmatic_JJ strategy_NN to_TO obtain_VB the_DT corresponding_JJ sequences_NNS from_IN the_DT genome_NN of_IN L._NP infantum_NN ._SENT First_RB ,_, we_PP selected_VBD ,_, among_IN sequences_NNS possessing_VBG microsatellites_NNS ,_, those_DT of_IN less_JJR than_IN 1_CD kb_NN presenting_VBG coding_VBG sequences_NNS at_IN both_DT extremities_NNS ._SENT Second_RB ,_, we_PP selected_VBD primers_NNS that_WDT recognized_VBD the_DT coding_VBG part_NN of_IN the_DT sequences_NNS and_CC performed_VBD PCR_NP ,_, with_IN DNA_NP from_IN L._NP infantum_NN as_IN the_DT template_NN ._SENT Third_JJ ,_, we_PP sequenced_VBD PCR_NP products_NNS to_TO locate_VB the_DT microsatellites_NNS and_CC design_VB new_JJ primers_NNS closer_RBR to_TO these_DT regions_NNS ._SENT Finally_RB ,_, we_PP selected_VBD three_CD DNA_NN targets_NNS in_IN the_DT genome_NN of_IN L._NP infantum_NN ._SENT Two_CD of_IN these_DT targets_NNS corresponded_VBD to_TO sequences_NNS originally_RB found_VBD in_IN the_DT genome_NN of_IN L._NP major_JJ ,_, one_CD which_WDT contains_VBZ three_CD microsatellites_NNS (_( the_DT Lm2_NP sequence_NN )_) and_CC another_DT which_WDT contains_VBZ four_CD microsatellites_NNS (_( the_DT Lm4_NP sequence_NN )_) ._SENT The_DT third_JJ target_NN was_VBD the_DT internal_JJ transcribed_VBN spacer_NN (_( ITS_JJ )_) region_NN ,_, which_WDT contains_VBZ three_CD additional_JJ microsatellites_NNS ._SENT Strains_NNS ._SENT |_SYM Fifty_NP strains_NNS were_VBD used_VBN in_IN this_DT study_NN ._SENT They_PP were_VBD isolated_VBN from_IN 48_CD hosts_NNS in_IN three_CD Mediterranean_JJ countries_NNS :_: Spain_NP ,_, France_NP ,_, and_CC Israel_NP ._SENT Forty_NN of_IN them_PP had_VBD been_VBN characterized_VBN and_CC identified_VBN previously_RB as_IN L._NP infantum_NN by_IN isoenzyme_NN analysis_NN ._SENT In_IN two_CD cases_NNS ,_, two_CD strains_NNS were_VBD isolated_VBN from_IN separate_JJ samples_NNS collected_VBN from_IN the_DT same_JJ human_JJ host_NN (_( BCN_NP 143/BCN_NP 167_CD and_CC BCN_NP 224/BCN_NP 226_CD )_) during_IN successive_JJ episodes_NNS of_IN leishmaniasis_NN ._SENT Fourteen_NN strains_NNS were_VBD collected_VBN in_IN Provence_NP ,_, France_NP ._SENT This_DT region_NN represents_VBZ a_DT homogeneous_JJ focus_NN in_IN terms_NNS of_IN leishmanial_NN parasites_NNS because_IN all_PDT the_DT strains_NNS collected_VBN from_IN it_PP so_RB far_RB have_VBP belonged_VBN to_TO the_DT zymodeme_NN MON-1_NN ,_, including_VBG those_DT isolated_VBN from_IN patients_NNS coinfected_VBN with_IN HIV_NP ._SENT Twenty_CD strains_NNS were_VBD isolated_VBN in_IN Catalonia_NP ,_, Spain_NP ,_, from_IN dogs_NNS and_CC both_DT immunocompromised_JJ and_CC immunocompetent_JJ patients_NNS ._SENT The_DT Catalonian_NP focus_NN is_VBZ more_RBR heterogeneous_JJ in_IN its_PP$ leishmanial_NN parasites_NNS and_CC includes_VBZ strains_NNS belonging_VBG to_TO the_DT predominant_JJ zymodeme_NN MON-1_JJ and_CC other_JJ zymodemes_NNS (_( MON-24_NP ,_, MON-29_NP ,_, MON-33_NP ,_, MON-34_NP ,_, and_CC MON-80_NP )_) ._SENT Additional_JJ Spanish_JJ strains_NNS ,_, all_RB belonging_VBG to_TO MON-1_NP ,_, were_VBD collected_VBN in_IN Madrid_NP from_IN dogs_NNS ._SENT Ten_CD strains_NNS came_VBD from_IN central_JJ and_CC northern_JJ Israel_NP ._SENT Canine_JJ leishmaniasis_NN has_VBZ recently_RB reemerged_VBN in_IN central_JJ Israel_NP after_IN an_DT apparent_JJ absence_NN of_IN more_JJR than_IN 40_CD years_NNS ._SENT All_DT 10_CD strains_NNS were_VBD ,_, essentially_RB ,_, isolated_VBN from_IN dogs_NNS ._SENT One_CD of_IN them_PP ,_, strain_VB LRC-L760*_NP ,_, was_VBD isolated_VBN from_IN a_DT colony-bred_JJ sandfly_NN ,_, a_DT South_NP American_NP Lutzomyia_NP longipalpis_NP ,_, that_WDT had_VBD fed_VBN on_IN a_DT local_JJ dog_NN undergoing_VBG treatment_NN with_IN allopurinol_NN during_IN xenodiagnosis_NN ._SENT Its_PP$ sibling_NN strain_NN ,_, LRC-L760_NP ,_, isolated_VBN from_IN the_DT same_JJ dog_NN before_IN treatment_NN directly_RB into_IN rabbit_NN blood_NN agar_NN semisolid_JJ medium_NN was_VBD identified_VBN as_IN L._NP infantum_NN zymodeme_NN MON-1_JJ by_IN isoenzyme_NN analysis_NN ._SENT The_DT other_JJ nine_CD Israeli_JJ strains_NNS were_VBD not_RB characterized_VBN by_IN isoenzyme_NN analysis_NN ._SENT However_RB ,_, 13_CD other_JJ Israeli_JJ strains_NNS of_IN L._NP infantum_NN from_IN dogs_NNS and_CC humans_NNS sent_VBD to_TO Montpellier_NP ,_, France_NP ,_, for_IN isoenzyme_NN analysis_NN were_VBD all_DT zymodeme_NN MON-1_NN ._SENT In_IN addition_NN ,_, the_DT primers_NNS used_VBN in_IN this_DT study_NN were_VBD tested_VBN on_IN one_CD strain_NN of_IN L._NP major_JJ (_( LPM_NP 193_CD )_) (_( data_NNS not_RB shown_VBN )_) ._SENT This_DT strain_NN belongs_VBZ to_TO zymodeme_NP MON-26_NP and_CC was_VBD isolated_VBN in_IN 1999_CD from_IN a_DT patient_NN from_IN Saudi_NP Arabia_NP with_IN CL_NP ._SENT Isolation_NN and_CC growth_NN of_IN parasites_NNS ._SENT |_SYM The_DT strains_NNS were_VBD isolated_VBN and_CC grown_VBN as_IN promastigotes_NNS on_IN Novy-MacNeal-Nicolle_NP biphasic_JJ culture_NN medium_NN ._SENT DNA_NP preparation_NN ._SENT |_SYM The_DT total_JJ DNA_NN was_VBD extracted_VBN from_IN the_DT promastigotes_NNS for_IN PCR_NP amplification_NN ._SENT Samples_NNS of_IN 100_CD mul_NN of_IN culture_NN were_VBD washed_VBN in_IN 0.3_CD %_NN NaCl_NP ._SENT The_DT pellet_NN was_VBD lysed_VBN by_IN heating_NN at_IN 96C_NN for_IN 20_CD min_NN with_IN 400_CD mul_NN of_IN a_DT mixture_NN containing_VBG 1_CD %_NN Tween_NP 20_CD (_( Sigma_NP ,_, St._NP Louis_NP ,_, Mo._NP )_) ,_, 1_CD %_NN Nonidet_NP P-40_NP (_( Sigma_NP )_) ,_, and_CC 20_CD %_NN Chelex_NP resin_NN (_( Bio-Rad_NP ,_, Hercules_NP ,_, Calif._NP )_) made_VBD up_RP in_IN sterile_JJ distilled_JJ water_NN ._SENT The_DT mixture_NN was_VBD then_RB centrifuged_VBN at_IN 14,000_CD x_NN g_NN for_IN 10_CD min_NN at_IN room_NN temperature_NN ._SENT The_DT supernatant_JJ was_VBD collected_VBN and_CC was_VBD either_RB used_VBN immediately_RB for_IN PCR_NP amplification_NN or_CC stored_VBD at_IN -20C_NN until_IN used_VBN ._SENT PCR_NP amplification_NN ._SENT |_SYM Three_NP PCRs_NP were_VBD performed_VBN ._SENT The_DT primers_NNS A2_NP (_( 5'-GGGAGAAGCTCTATTGTG-3_NP '_POS )_) and_CC B1_NP (_( 5'-ACACTCAGGTCTGTAAAC-3_NP '_POS )_) were_VBD used_VBN for_IN analyzing_VBG the_DT ITS_JJ region_NN ,_, and_CC primers_NNS Lm4A1_JJ (_( 5'-CGGTGCACATTCGACCGCTA-3_JJ '_'' )_) and_CC Lm4B1_NP (_( 5'-ATGGCACGGTGCACGCTTCC-3_NP '_POS )_) were_VBD used_VBN for_IN amplifying_VBG the_DT Lm4_NP sequence_NN ._SENT Two_CD pairs_NNS of_IN primers_NNS were_VBD used_VBN to_TO amplify_VB the_DT Lm2_NP sequence_NN ._SENT First_RB ,_, we_PP amplified_VBD the_DT Lm2_JJ sequence_NN with_IN Lm2A1_NP (_( 5'-TGACGCGACGTGGCAAGTCA-3_NP '_POS )_) and_CC Lm2B1_NP (_( 5'-CCGTGAAGTACTCGGACGCT-3_NP '_POS )_) ,_, primers_NNS that_WDT recognize_VBP a_DT 900-bp-long_JJ fragment_NN ._SENT Then_RB we_PP used_VBD internal_JJ primers_NNS ,_, Lm2A3_NP (_( 5'-AAAAAGCGAGGAATGAAAGAA-3_NP '_POS )_) and_CC Lm2B3_NP (_( 5'-TAGAGGCGTGGCAGAGAC-3_NP '_POS )_) ,_, which_WDT were_VBD localized_VBN on_IN either_DT side_NN of_IN the_DT most_RBS variable_JJ microsatellite_NN ,_, for_IN sequencing_VBG the_DT complete_JJ Lm2_JJ fragment_NN in_IN both_DT directions_NNS ._SENT All_PDT the_DT primers_NNS were_VBD synthesized_VBN by_IN Eurogentec_NP (_( Seraing_NP ,_, Belgium_NP )_) ._SENT Each_DT reaction_NN mixture_NN (_( 50_CD mul_NN )_) contained_VBD a_DT 0.05_CD mM_NP concentration_NN of_IN each_DT deoxynucleoside_NN triphosphate_NN ,_, a_DT 0.5_CD muM_NN concentration_NN of_IN each_DT primer_NN ,_, 1x_NP REDtaq_NP buffer_NN ,_, 1_CD U_NP of_IN REDtaq_NP polymerase_NN (_( Sigma_NP )_) ,_, and_CC 5_CD mul_NN of_IN total_JJ DNA_NN extract_NN ._SENT After_IN a_DT 2-min_JJ incubation_NN at_IN 94C_NN ,_, amplification_NN of_IN either_CC the_DT ITS_JJ region_NN or_CC the_DT Lm2_NP and_CC Lm4_NP sequences_NNS was_VBD performed_VBN for_IN 40_CD or_CC 35_CD cycles_NNS ,_, respectively_RB ,_, in_IN an_DT automated_JJ thermocycler_NN PTJ_NP 100_CD (_( MJ_NP Research_NP ,_, Inc_NP ,_, Watertown_NP ,_, Mass._NP )_) ._SENT The_DT conditions_NNS used_VBN for_IN the_DT ITS_JJ region_NN were_VBD denaturation_NN at_IN 94C_NN for_IN 20_CD s_NNS ,_, primer_JJR annealing_VBG at_IN 53C_NN for_IN 30_CD s_NNS ,_, and_CC extension_NN at_IN 72C_NP for_IN 1_CD min_NN ._SENT The_DT conditions_NNS used_VBN for_IN the_DT other_JJ sequences_NNS were_VBD denaturation_NN for_IN 30_CD s_NNS at_IN 94C_NN ,_, primer_JJR annealing_VBG for_IN 30_CD s_NNS at_IN 63C_JJ ,_, and_CC extension_NN for_IN 1_CD min_NN at_IN 72C_NP for_IN the_DT Lm4_NP sequence_NN ;_: denaturation_NN for_IN 30_CD s_NNS at_IN 94C_NN ,_, primer_JJR annealing_VBG for_IN 30_CD s_NNS at_IN 62C_JJ ,_, and_CC extension_NN for_IN 90_CD s_NNS at_IN 72C_NP for_IN the_DT Lm2_NP sequence_NN with_IN the_DT Lm2A1_NP and_CC Lm2B1_NP primers_NNS ;_: and_CC denaturation_NN for_IN 30_CD s_NNS at_IN 94C_NN ,_, primer_JJR annealing_VBG for_IN 30_CD s_NNS at_IN 51C_NN ,_, and_CC extension_NN for_IN 1_CD min_NN at_IN 72C_NP for_IN the_DT Lm2_NP sequence_NN with_IN the_DT Lm2A3_NP and_CC Lm2B3_NP primers_NNS ._SENT After_IN amplification_NN ,_, 10_CD mul_NN of_IN PCR_NP products_NNS was_VBD visualized_VBN by_IN electrophoresis_NN on_IN a_DT 1.5_CD %_NN agarose_NN gel_NN containing_VBG ethidium_NN bromide_NN ._SENT DNA_NP sequencing_NP ._SENT |_SYM Amplified_NP DNA_NP was_VBD purified_VBN by_IN using_VBG the_DT QIAquick_NP PCR_NP purification_NN kit_NN (_( Qiagen_NP SA_NP ,_, Courtaboeuf_NP ,_, France_NP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS recommendations_NNS ._SENT The_DT purified_VBN DNA_NN for_IN each_DT strain_NN was_VBD then_RB sequenced_JJ in_IN both_DT directions_NNS with_IN a_DT fluorescent_JJ labeling_VBG kit_NN (_( Thermo_NP Sequenase_NP II_NP kit_NN ;_: Amersham_NP Pharmacia_NP Biotech_NP Europe_NP ,_, Orsay_NP ,_, France_NP )_) with_IN specific_JJ primers_NNS on_IN an_DT automated_JJ DNA_NN sequencer_NN 373A_NP (_( Perkin_NP Elmer_NP Applied_NP Biosystems_NP ,_, Foster_NP City_NP ,_, Calif._NP )_) ._SENT In_IN some_DT cases_NNS ,_, the_DT results_NNS obtained_VBN by_IN direct_JJ sequencing_NP of_IN Lm2_NP PCR_NP products_NNS were_VBD confirmed_VBN after_IN cloning_VBG the_DT PCR_NP products_NNS into_IN the_DT vector_NN pCR_NN 2.1_CD (_( TA_NP Cloning_NP kit_NN ;_: Invitrogen_NP ,_, Leek_NP ,_, The_DT Netherlands_NPS )_) ._SENT Phenetic_JJ dendrogram_NN ._SENT |_SYM The_DT ITS_NN ,_, Lm2_NP ,_, and_CC Lm4_NP sequences_NNS obtained_VBN for_IN each_DT different_JJ genotype_NN were_VBD aligned_VBN ,_, and_CC a_DT dendrogram_NN was_VBD calculated_VBN with_IN the_DT fastDNAml_NN software_NN (_( version_NN 1.2.2_CD )_) ._SENT TREEVIEW_NP ,_, a_DT tree_NN drawing_NN software_NN ,_, was_VBD used_VBN to_TO produce_VB the_DT tree_NN ._SENT Reproducibility_NN of_IN PCR_NP and_CC stability_NN of_IN the_DT genotypes_NNS ._SENT |_SYM Reproducibility_NN was_VBD assessed_VBN by_IN repeating_VBG the_DT preparation_NN of_IN the_DT DNA_NN from_IN the_DT two_CD strains_NNS UCM_NP 1_CD and_CC LPM_NP 191_CD six_CD times_NNS followed_VBN by_IN amplification_NN and_CC sequencing_VBG of_IN all_DT of_IN the_DT samples_NNS ._SENT In_IN addition_NN ,_, the_DT primers_NNS A2_NP and_CC B1_NP were_VBD used_VBN repetitively_RB ,_, six_CD times_NNS ,_, to_TO amplify_VB the_DT ITS_JJ sequence_NN from_IN three_CD DNA_NN extracts_VBZ of_IN the_DT strains_NNS BCN_NP 1_CD ,_, BCN_NP 143_CD ,_, and_CC BCN_NP 226_CD ._SENT Similarly_RB ,_, six_CD amplifications_NNS were_VBD performed_VBN with_IN DNA_NN isolated_VBN from_IN the_DT five_CD strains_NNS BCN_NP 1_CD ,_, BCN_NP 143_CD ,_, BCN_NP 235_CD ,_, BCN_NP 258_CD ,_, and_CC LPM_NP 191_CD with_IN the_DT primers_NNS Lm4A1_NP and_CC Lm4B1_NP ._SENT We_PP also_RB verified_VBD the_DT stability_NN of_IN the_DT strains_NNS in_IN vitro_NN and_CC in_IN vivo_RB ._SENT After_IN culturing_VBG the_DT promastigotes_NNS of_IN strains_NNS BCN_NP 1_CD ,_, BCN_NP 224_CD ,_, and_CC LPM_NP 195_CD in_IN six_CD different_JJ batches_NNS of_IN Novy-MacNeal-Nicolle_NP medium_NN over_IN 3_CD months_NNS ,_, their_PP$ DNAs_NP were_VBD isolated_VBN and_CC PCRs_NNS were_VBD performed_VBN for_IN the_DT three_CD molecular_JJ targets_NNS ._SENT In_IN parallel_JJ ,_, total_JJ DNA_NN was_VBD extracted_VBN at_IN each_DT stage_NN from_IN the_DT leishmanial_NN promastigotes_NNS of_IN strain_NN BCN_NP 83_CD grown_VBN directly_RB after_IN isolation_NN from_IN a_DT dog_NN ,_, regrown_JJ after_IN passage_NN through_IN and_CC reisolation_NN from_IN a_DT hamster_NN ,_, and_CC then_RB regrown_JJ after_IN passage_NN through_IN and_CC reisolation_NN from_IN another_DT dog_NN ._SENT All_DT of_IN these_DT DNA_NP extracts_VBZ were_VBD submitted_VBN to_TO PCR_NP amplification_NN and_CC sequencing_VBG ._SENT TABLE_NN 1_CD |_SYM Main_JJ features_NNS of_IN strains_NNS of_IN L._NP infantum_NN collected_VBN in_IN three_CD Mediterranean_JJ foci_NNS Sequence_NN analysis_NN of_IN the_DT PCR-amplified_JJ ITS_JJ region_NN with_IN primers_NNS A2_NP and_CC B1_NP ._SENT |_SYM All_NP strains_NNS gave_VBD an_DT amplified_VBN fragment_NN of_IN about_RB 650_CD bp_NN ._SENT The_DT A2B1_JJ part_NN of_IN the_DT ITS_JJ sequence_NN contained_VBD three_CD microsatellites_NNS exhibiting_VBG a_DT moderate_JJ degree_NN of_IN size_NN polymorphism_NN :_: the_DT number_NN of_IN AT_JJ repeat_NN units_NNS was_VBD 5_CD or_CC 6_CD ,_, the_DT cluster_NN TA_NP was_VBD repeated_VBN 4_CD or_CC 5_CD times_NNS ,_, and_CC the_DT number_NN of_IN G_NP repeat_NN units_NNS was_VBD 5_CD ,_, 7_CD ,_, or_CC 8_CD ._SENT Three_CD different_JJ sequences_NNS were_VBD found_VBN among_IN the_DT strains_NNS from_IN Catalonia_NP ,_, whereas_IN all_DT strains_NNS from_IN Madrid_NP ,_, Provence_NP ,_, and_CC Israel_NP had_VBD the_DT same_JJ sequence_NN ._SENT Sequence_NN analysis_NN of_IN the_DT Lm2_NP and_CC Lm4_NP fragments_NNS ._SENT |_SYM Amplification_NP of_IN the_DT Lm2_NP region_NN generated_VBD an_DT amplified_VBN fragment_NN of_IN about_RB 900_CD bp_NN for_IN L._NP infantum_NN and_CC one_CD of_IN about_RB 750_CD bp_NN for_IN L._NP major_JJ ._SENT The_DT Lm2_NP sequence_NN exhibited_VBD four_CD microsatellites_NNS ._SENT Three_CD of_IN them_PP corresponding_JJ to_TO a_DT C7_JJ microsatellite_NN ,_, a_DT (CA)8_JJ microsatellite_NN ,_, and_CC an_DT imperfect_JJ (TG)8-CG-(TG)5_NN microsatellite_NN were_VBD identical_JJ among_IN all_DT strains_NNS ._SENT The_DT last_JJ one_CD ,_, corresponding_VBG to_TO a_DT poly-TG_NN ,_, was_VBD highly_RB variable_JJ ;_: the_DT dinucleotide_NN was_VBD repeated_VBN 17_CD ,_, 22_CD ,_, 23_CD ,_, 24_CD ,_, 25_CD ,_, 26_CD ,_, or_CC 27_CD times_NNS ._SENT No_DT differences_NNS were_VBD found_VBN between_IN sequences_NNS obtained_VBN directly_RB after_IN PCR_NP or_CC after_IN cloning_VBG of_IN the_DT PCR_NP products_NNS ._SENT Finally_RB ,_, sequence_NN analysis_NN of_IN the_DT Lm2_NP PCR_NP products_NNS in_IN all_DT strains_NNS identified_VBD seven_CD profiles_NNS only_RB due_JJ to_TO the_DT size_NN variation_NN of_IN the_DT poly-TG_NN ._SENT Six_CD of_IN them_PP were_VBD found_VBN for_IN the_DT strains_NNS originating_VBG from_IN Catalonia_NP ._SENT Three_CD different_JJ Lm2_NP sequences_NNS were_VBD identified_VBN among_IN strains_NNS collected_VBN in_IN Provence_NP and_CC Israel_NP ._SENT Amplification_NN with_IN primers_NNS Lm4A1_NP and_CC Lm4B1_NP produced_VBD a_DT fragment_NN of_IN 560_CD bp_NN for_IN each_DT species_NN ,_, L._NP infantum_NP and_CC L._NP major_JJ ._SENT The_DT Lm4_NP region_NN contained_VBD three_CD microsatellites_NNS :_: poly-A_NP ,_, poly-T_NN ,_, and_CC poly-TA_NN ._SENT Two_CD of_IN them_PP were_VBD identical_JJ among_IN all_DT strains_NNS (_( A10_NP and_CC T9_NP )_) ,_, while_IN the_DT (TA)n_NN microsatellite_NN exhibited_VBD a_DT high_JJ level_NN of_IN size_NN polymorphism_NN ._SENT The_DT TA_NP unit_NN was_VBD repeated_VBN 9_CD ,_, 10_CD ,_, 11_CD ,_, 12_CD ,_, 13_CD ,_, or_CC 14_CD times_NNS ._SENT Finally_RB ,_, sequence_NN analysis_NN of_IN the_DT Lm4_NP PCR_NP products_NNS in_IN all_DT strains_NNS identified_VBD six_CD profiles_NNS due_JJ only_RB to_TO the_DT size_NN variation_NN of_IN the_DT poly-TA_NN ._SENT Strains_NNS from_IN Israel_NP had_VBD the_DT same_JJ Lm4_NP sequence_NN while_IN strains_NNS from_IN Madrid_NP ,_, Catalonia_NP ,_, and_CC Provence_NP gave_VBD three_CD ,_, four_CD ,_, and_CC five_CD different_JJ sequences_NNS ,_, respectively_RB ._SENT Reproducibility_NN of_IN PCR_NP and_CC stability_NN of_IN the_DT genotypes_NNS ._SENT |_SYM The_DT ITS_NN ,_, Lm2_NP ,_, and_CC Lm4_NP sequences_NNS obtained_VBN for_IN each_DT strain_NN were_VBD identical_JJ when_WRB six_CD different_JJ preparations_NNS of_IN the_DT same_JJ DNA_NN were_VBD used_VBN for_IN the_DT PCRs_NN or_CC when_WRB the_DT fragment_NN was_VBD amplified_VBN six_CD times_NNS by_IN using_VBG the_DT same_JJ DNA_NN ._SENT In_IN addition_NN ,_, the_DT ITS_NN ,_, Lm2_NP ,_, and_CC Lm4_NP sequences_NNS showed_VBD no_DT variations_NNS even_RB after_IN multiple_JJ generations_NNS in_IN vivo_JJ and_CC in_IN vitro_NN ._SENT Results_NNS comparison_NN ._SENT |_SYM The_NP ITS-_NP ,_, Lm2-_NP ,_, and_CC Lm4-associated_JJ sequences_NNS generated_VBD 22_CD genotypes_NNS for_IN 50_CD strains_NNS of_IN L._NP infantum_NN belonging_VBG to_TO six_CD zymodemes_NNS ._SENT In_IN particular_JJ ,_, the_DT MON-1_NP strains_NNS gave_VBD thirteen_CD different_JJ genotypes_NNS that_WDT were_VBD closely_RB related_VBN to_TO each_DT other_JJ ._SENT In_IN addition_NN ,_, DNA_NN typing_VBG of_IN strains_NNS MON-33_NP and_CC MON-34_NP gave_VBD two_CD different_JJ genotypes_NNS that_WDT were_VBD closely_RB related_VBN to_TO the_DT MON-1_JJ genotype_NN ._SENT On_IN the_DT other_JJ hand_NN ,_, strains_VBZ MON-29_NP ,_, MON-24_NP ,_, and_CC MON-80_NP showed_VBD more-divergent_JJ genotypes_NNS ._SENT Even_RB when_WRB more_JJR than_IN one_CD strain_NN was_VBD isolated_VBN from_IN the_DT same_JJ patient_NN ,_, the_DT strains_NNS still_RB had_VBD identical_JJ genotypes_NNS ._SENT Strains_NNS collected_VBN in_IN the_DT Provence_NP region_NN ,_, which_WDT all_RB belong_VBP to_TO the_DT zymodeme_NN MON-1_NP ,_, gave_VBD nine_CD different_JJ genotypes_NNS ,_, while_IN the_DT 10_CD L._NP infantum_NN strains_NNS originating_VBG from_IN northern_JJ and_CC central_JJ Israel_NP resulted_VBD in_IN only_RB three_CD genotypes_NNS ._SENT FIG._NN 1_CD ._SENT |_SYM Complete_JJ nucleotide_NN sequences_NNS of_IN genomic_JJ DNA_NN regions_NNS containing_VBG microsatellites_NNS from_IN strains_NNS of_IN L._NP infantum_NP Complete_JJ nucleotide_NN sequences_NNS of_IN genomic_JJ DNA_NN regions_NNS containing_VBG microsatellites_NNS from_IN strains_NNS of_IN L._NP infantum_NN ._SENT Microsatellites_NNS are_VBP shown_VBN in_IN bold_JJ type_NN ._SENT The_DT superscripts_NNS indicate_VBP the_DT minimum_JJ and_CC maximum_JJ numbers_NNS of_IN repeat_NN units_NNS found_VBN for_IN each_DT microsatellite_NN ._SENT (_( A_NP )_) Nucleotide_NN sequence_NN of_IN PCR_NP product_NN determined_VBN with_IN primers_NNS A2_NP and_CC B1_NP ._SENT (_( B_NP )_) Nucleotide_NN sequence_NN of_IN PCR_NP product_NN determined_VBD first_JJ with_IN primers_NNS Lm2A1_NP and_CC Lm2B1_NP and_CC then_RB with_IN primers_NNS Lm2A3_NP and_CC Lm2B3_NP ._SENT The_DT internal_JJ primers_NNS ,_, Lm2A3_NP and_CC Lm2B3_NP ,_, are_VBP underlined_VBN ._SENT (_( C_NP )_) Nucleotide_NN sequence_NN of_IN PCR_NP product_NN determined_VBN with_IN primers_NNS Lm4A1_NP and_CC Lm4B1_NP ._SENT FIG._NN 2_CD ._SENT |_SYM Dendrogram_NP calculated_VBN with_IN fastDNAml_NN (_( version_NN 1_CD ._SENT Dendrogram_NN calculated_VBN with_IN fastDNAml_NN (_( version_NN 1.2.2_CD )_) ,_, which_WDT is_VBZ based_VBN in_IN part_NN on_IN Felsenstein_NP 's_POS nucleic_JJ acid_JJ sequence_NN maximum_NN likelihood_NN method_NN (_( version_NN 3.3_CD )_) ,_, and_CC elaborated_VBD with_IN TREEVIEW_NP tree_NN drawing_NN software_NN ._SENT Each_DT genotype_NN is_VBZ characterized_VBN by_IN its_PP$ microsatellite_NN combination_NN (_( ITS-Lm2-Lm4_NP )_) ,_, its_PP$ zymodeme_NN ,_, and_CC its_PP$ geographical_JJ origin_NN ._SENT C_NP ,_, Catalonia_NP ;_: M_NP ,_, Madrid_NP ;_: P_NN ,_, Provence_NP ;_: I_NP ,_, Israel_NP ;_: #_# ,_, the_DT zymodeme_NN is_VBZ not_RB available_JJ for_IN all_DT of_IN the_DT samples_NNS of_IN the_DT genotype_NN ._SENT TABLE_NN 2_CD |_SYM Comparison_NN of_IN isoenzyme_NN analysis_NN and_CC DNA_NN typing_VBG by_IN microsatellite_NN size_NN polymorphism_NN with_IN L._NP infantum_NN We_PP have_VBP developed_VBN a_DT reproducible_JJ ,_, discriminating_VBG molecular_JJ typing_VBG system_NN that_WDT was_VBD able_JJ to_TO characterize_VB and_CC distinguish_VB closely_RB related_VBN strains_NNS of_IN L._NP infantum_NN collected_VBN in_IN three_CD Mediterranean_JJ countries_NNS :_: France_NP ,_, Spain_NP ,_, and_CC Israel_NP ._SENT It_PP is_VBZ based_VBN on_IN the_DT comparative_JJ analysis_NN of_IN PCR_NP products_NNS from_IN three_CD nuclear_JJ noncoding_JJ DNA_NN sequences_NNS containing_VBG polymorphic_JJ microsatellites_NNS ._SENT The_DT partial_JJ screening_NN of_IN a_DT leishmanial_NN genomic_JJ library_NN was_VBD not_RB needed_VBN to_TO identify_VB these_DT microsatellites_NNS ._SENT Instead_RB ,_, polymorphic_JJ targets_NNS were_VBD selected_VBN from_IN among_IN complete_JJ DNA_NN sequences_NNS published_VBN in_IN data_NNS banks_NNS ._SENT Since_IN many_JJ such_JJ sequences_NNS are_VBP available_JJ in_IN the_DT gene_NN data_NN banks_NNS ,_, this_DT strategy_NN can_MD be_VB applied_VBN to_TO the_DT molecular_JJ typing_VBG of_IN other_JJ eukaryotic_JJ microorganisms_NNS ._SENT One_CD major_JJ advantage_NN of_IN this_DT approach_NN is_VBZ its_PP$ simplification_NN of_IN Leishmania_NP strain_NN typing_VBG in_IN the_DT Mediterranean_JJ region_NN ._SENT By_IN employing_VBG parasite-specific_JJ primers_NNS to_TO polymorphic_JJ microsatellites_NNS ,_, parasite_NN culturing_VBG may_MD be_VB avoided_VBN in_IN many_JJ cases_NNS ._SENT PCR_NP could_MD be_VB carried_VBN out_RP directly_RB with_IN infected_JJ host_NN tissue_NN ,_, since_IN nonspecific_JJ amplification_NN of_IN human_JJ or_CC dog_NN DNA_NN with_IN these_DT primers_NNS was_VBD not_RB observed_JJ (_( data_NNS not_RB shown_VBN )_) ._SENT In_IN addition_NN ,_, this_DT approach_NN for_IN typing_VBG strains_NNS of_IN Leishmania_NP is_VBZ rapid_JJ ._SENT It_PP takes_VBZ just_RB a_DT few_JJ days_NNS to_TO perform_VB DNA_NN extraction_NN ,_, amplification_NN by_IN PCR_NP ,_, and_CC sequencing_NP ,_, whereas_IN isoenzyme_NN analysis_NN ,_, which_WDT is_VBZ still_RB the_DT "_`` gold_JJ standard_NN ,_, "_`` may_MD take_VB several_JJ months_NNS from_IN strain_NN isolation_NN through_IN culture_NN to_TO provide_VB a_DT full_JJ enzyme_NN profile_NN and_CC zymodeme_NN designation_NN ._SENT The_DT usefulness_NN of_IN isoenzyme_NN analysis_NN for_IN epidemiological_JJ and_CC taxonomic_JJ studies_NNS has_VBZ been_VBN widely_RB proven_VBN ,_, but_CC microsatellite_NN analysis_NN seems_VBZ to_TO be_VB more_RBR discriminating_JJ with_IN the_DT 15_CD different_JJ genotypes_NNS found_VBN for_IN MON-1_NP in_IN our_PP$ study_NN ._SENT This_DT genetic_JJ heterogeneity_NN of_IN strains_NNS belonging_VBG to_TO one_CD zymodeme_NN has_VBZ been_VBN observed_VBN for_IN other_JJ approaches_NNS based_VBN on_IN DNA_NN microheterogeniety_NN ,_, such_JJ as_IN RAPD_NP and_CC RFLP_NP PCR_NP methods_NNS ._SENT The_DT new_JJ typing_VBG approach_NN presented_VBD here_RB is_VBZ very_RB reproducible_JJ ;_: repeat_NN testing_NN of_IN the_DT same_JJ isolate_NN after_IN multiple_JJ generations_NNS in_IN vivo_JJ and_CC in_IN vitro_NN gave_VBD identical_JJ sequences_NNS ._SENT However_RB ,_, in_IN some_DT cases_NNS ,_, sequences_NNS of_IN very_RB long_JJ microsatellites_NNS ,_, such_JJ as_IN the_DT poly-TG_NN found_VBD in_IN the_DT Lm2_NP sequence_NN ,_, were_VBD quite_RB difficult_JJ to_TO read_VB ,_, and_CC ambiguities_NNS were_VBD observed_VBN at_IN the_DT end_NN of_IN the_DT microsatellite_NN ._SENT These_DT ambiguities_NNS could_MD be_VB resolved_VBN by_IN sequencing_VBG the_DT reverse_JJ DNA_NN strand_NN ._SENT Since_IN sequences_NNS obtained_VBN after_IN PCR_NP cloning_VBG were_VBD strictly_RB identical_JJ ,_, we_PP think_VBP that_IN this_DT problem_NN does_VBZ not_RB reflect_VB a_DT sequence_NN polymorphism_NN within_IN the_DT population_NN of_IN Leishmania_NP in_IN the_DT sample_NN ._SENT This_DT problem_NN is_VBZ more_RBR likely_RB due_JJ to_TO DNA_NN polymerase_NN misreading_VBG during_IN PCR_NP amplification_NN ._SENT Among_IN the_DT three_CD sequences_NNS (_( ITS_NP ,_, Lm2_NP ,_, and_CC Lm4_NP )_) analyzed_VBD ,_, only_RB the_DT microsatellite_NN region_NN was_VBD variable_JJ and_CC size_NN polymorphism_NN was_VBD the_DT only_JJ variation_NN noted_VBD in_IN the_DT microsatellites_NNS ._SENT No_DT exchanges_NNS of_IN bases_NNS were_VBD seen_VBN in_IN or_CC around_IN microsatellite_NN clusters_NNS ._SENT This_DT is_VBZ probably_RB due_JJ to_TO the_DT fact_NN that_IN all_DT strains_NNS of_IN the_DT panel_NN are_VBP closely_RB related_VBN ._SENT As_IN microsatellites_NNS exhibit_VBP only_JJ size_NN variation_NN and_CC sequencing_VBG of_IN very_RB long_JJ microsatellites_NNS is_VBZ sometimes_RB difficult_JJ to_TO perform_VB ,_, it_PP should_MD be_VB possible_JJ to_TO improve_VB this_DT technique_NN further_RBR ._SENT Indeed_RB ,_, size_NN polymorphism_NN of_IN microsatellites_NNS could_MD be_VB evaluated_VBN by_IN acrylamide_NN gel_NN electrophoresis_NN of_IN fluorescein-labeled_JJ PCR_NP products_NNS ._SENT This_DT would_MD save_VB time_NN and_CC expense_NN because_IN DNA_NP sequencing_NP of_IN the_DT PCR_NP products_NNS could_MD be_VB avoided_VBN ._SENT The_DT microsatellites_NNS analyzed_VBD here_RB displayed_VBN variable_JJ levels_NNS of_IN polymorphism_NN that_WDT may_MD be_VB related_VBN to_TO the_DT number_NN of_IN repeat_NN units_NNS and/or_CC the_DT composition_NN of_IN the_DT microsatellite_NN ._SENT To_TO verify_VB this_DT hypothesis_NN ,_, analysis_NN of_IN more_JJR microsatellites_NNS would_MD clearly_RB be_VB useful_JJ ._SENT These_DT data_NNS could_MD be_VB used_VBN to_TO select_VB more_JJR polymorphic_JJ microsatellites_NNS and_CC increase_VB the_DT discriminatory_JJ power_NN of_IN such_JJ typing_VBG methods_NNS ._SENT In_IN addition_NN ,_, it_PP is_VBZ important_JJ to_TO note_VB that_IN our_PP$ results_NNS are_VBP not_RB in_IN contradiction_NN with_IN the_DT isoenzyme_NN typing_VBG data_NNS ._SENT Between_IN the_DT different_JJ foci_NNS of_IN leishmaniasis_NN analyzed_VBD ,_, the_DT polymorphism_NN observed_VBD with_IN the_DT five_CD microsatellites_NNS varied_VBD ._SENT The_DT Catalonian_NP focus_NN displayed_VBD the_DT highest_JJS genomic_JJ polymorphism_NN and_CC probably_RB reflects_VBZ the_DT isoenzyme_NN polymorphism_NN observed_VBD in_IN that_DT region_NN ._SENT The_DT Israeli_JJ focus_NN displayed_VBN less_RBR genomic_JJ polymorphism_NN among_IN its_PP$ strains_NNS ,_, perhaps_RB correlated_VBN with_IN the_DT recent_JJ reemergence_NN and_CC rapid_JJ spread_NN of_IN canine_JJ leishmaniasis_NN caused_VBN by_IN L._NP infantum_NN in_IN northern_JJ and_CC central_JJ Israel_NP ._SENT The_DT strains_NNS originating_VBG from_IN the_DT south_NN of_IN France_NP displayed_VBD significant_JJ microsatellite_NN size_NN polymorphism_NN even_RB though_IN they_PP were_VBD monomorphic_JJ by_IN enzyme_NN analysis_NN ._SENT Concerning_VBG the_DT Madrid_NP focus_NN ,_, its_PP$ relative_JJ stability_NN (_( 1_CD zymodeme_NN and_CC 4_CD closely_RB related_VBN genotypes_NNS )_) seems_VBZ to_TO be_VB correlated_VBN with_IN the_DT smaller_JJR area_NN in_IN which_WDT the_DT strains_NNS were_VBD obtained_VBN ._SENT To_TO date_NN ,_, we_PP have_VBP only_RB studied_VBN strains_NNS of_IN L._NP infantum_NN isolated_VBN from_IN humans_NNS and_CC dogs_NNS ._SENT However_RB ,_, it_PP should_MD be_VB possible_JJ to_TO use_VB microsatellite_JJ variation_NN to_TO study_VB the_DT genetic_JJ diversity_NN of_IN leishmanial_NN parasites_NNS from_IN all_DT of_IN the_DT possible_JJ different_JJ situations_NNS ,_, i.e._FW ,_, different_JJ clinical_JJ presentations_NNS ,_, human_JJ (_( immunocompromised_JJ or_CC immunocompetent_JJ children_NNS )_) and_CC animal_JJ (_( dogs_NNS and_CC wild_JJ canids_NNS )_) hosts_VBZ ,_, and_CC sandfly_NN vectors_NNS existing_VBG in_IN the_DT same_JJ area_NN of_IN endemicity_NN ._SENT Microsatellites_NNS might_MD also_RB prove_VB useful_JJ in_IN determining_VBG whether_IN or_CC not_RB there_EX is_VBZ any_DT relationship_NN between_IN genotype_NN and_CC the_DT pathogenicity_NN of_IN Leishmania_NP strains_NNS ._SENT This_DT technique_NN could_MD be_VB useful_JJ in_IN discerning_VBG whether_IN specific_JJ leishmanial_NN genotypes_NNS confer_VBP host_NN specificity_NN and_CC if_IN leishmanial_NN parasite_NN diversity_NN is_VBZ consistent_JJ in_IN different_JJ hosts_NNS ._SENT In_IN conclusion_NN ,_, microsatellite_NN polymorphism_NN is_VBZ simply_RB and_CC rapidly_RB detected_VBN by_IN PCR_NP ,_, displays_VBZ a_DT high_JJ level_NN of_IN reproducibility_NN ,_, and_CC exhibits_VBZ a_DT high_JJ level_NN of_IN discrimination_NN ._SENT It_PP is_VBZ suitable_JJ for_IN characterizing_VBG closely_RB related_VBN strains_NNS of_IN L._NP infantum_NN ._SENT Since_IN many_JJ sequences_NNS are_VBP published_VBN in_IN existing_VBG data_NNS banks_NNS ,_, the_DT strategy_NN used_VBN here_RB could_MD be_VB applied_VBN to_TO the_DT molecular_JJ typing_VBG of_IN other_JJ eukaryotic_JJ microorganisms_NNS ._SENT 